Federal award (DEFINITIVE CONTRACT, fiscal year 2021)
Recipient: LYRA THERAPEUTICS INC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2016-09-27 to 2020-11-30
Current total value of award: $1064068.64
Description: DEVELOPMENT LEADING TO THE COMMERCIALIZATION OF A BIORESORBABLE STENTS (BRS) FOR THE TREATMENT OF COARCTATION OF THE AORTA IN NEONATES